NCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
9 trialsNCT07005089 2025-06-05
Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts
Al-Azhar University
Phase NA Completed
NCT02317705 2022-06-21
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
On Target Laboratories, LLC
Phase 2 Completed
NCT03180307 2022-02-04
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
On Target Laboratories, LLC
Phase 3 Completed
NCT01705288 2020-02-17
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Completed
NCT02493972 2019-07-09
CARPEMAN
Centre Francois Baclesse
Phase NA Completed
NCT00002716 2016-07-13
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00008138 2016-01-08
S0009
SWOG Cancer Research Network
Phase 2 Completed
NCT00062933 2012-08-20
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed